M05.042 Felty's syndrome, left hand

Name of the Condition

• Felty's syndrome, left hand

Summary

Felty's syndrome is a rare complication of rheumatoid arthritis characterized by the triad of rheumatoid arthritis, splenomegaly (enlarged spleen), and neutropenia (low neutrophil count). When affecting the left hand, it involves chronic inflammation of the hand joints alongside systemic manifestations. The condition typically occurs in individuals with long-standing, severe rheumatoid arthritis and is associated with increased susceptibility to infections due to neutropenia.

Causes

Felty's syndrome is considered a variant of rheumatoid arthritis, though its exact cause is not fully understood. It is thought to result from chronic inflammation and immune dysregulation, leading to splenic sequestration of neutrophils and bone marrow suppression. The condition is strongly associated with high titers of rheumatoid factor and anti-citrullinated protein antibodies (ACPA). Left hand involvement occurs as part of the broader rheumatoid arthritis process affecting multiple joints.

Risk Factors

• Long-standing, severe rheumatoid arthritis
• High titers of rheumatoid factor
• Presence of anti-citrullinated protein antibodies (ACPA)
• Advanced age (typically over 50 years)
• Female gender (more commonly affected)

Symptoms

• Persistent joint pain, swelling, and stiffness in the left hand from underlying rheumatoid arthritis
• Fatigue and weakness
• Recurrent infections due to neutropenia
• Abdominal discomfort or fullness from splenomegaly
• Unexplained weight loss
• Skin discoloration or ulcers (less common)

Diagnosis

Diagnosis of Felty's syndrome, left hand, requires confirmation of the triad of rheumatoid arthritis, splenomegaly, and neutropenia. Clinical evaluation includes assessing joint inflammation, spleen size, and blood counts. Laboratory tests may include complete blood count (CBC) to confirm neutropenia, rheumatoid factor, and anti-citrullinated protein antibodies. Imaging studies, such as ultrasound or CT, may be used to evaluate splenomegaly. Exclusion of other causes of neutropenia and splenomegaly is essential for accurate diagnosis.

Treatment Options

Treatment focuses on managing rheumatoid arthritis and its complications. Disease-modifying antirheumatic drugs (DMARDs) are used to control joint inflammation. Granulocyte colony-stimulating factor (G-CSF) may be prescribed to address neutropenia and reduce infection risk. Splenectomy is rarely considered and reserved for severe cases. Supportive care includes infection prevention and management of anemia or thrombocytopenia if present.

Prognosis and Follow-Up

Prognosis depends on the severity of rheumatoid arthritis and response to treatment. Early intervention can improve outcomes, but the condition may progress with complications like infections or organ damage. Regular follow-up is necessary to monitor joint function, blood counts, and splenomegaly. Adjustments to therapy may be needed based on disease activity and complications.

Complications

• Increased risk of bacterial infections due to neutropenia
• Severe joint damage from rheumatoid arthritis
• Anemia or thrombocytopenia
• Splenic rupture (rare)
• Increased mortality from infections or systemic inflammation

Lifestyle & Prevention

• Maintain regular medical care to manage rheumatoid arthritis
• Practice good hygiene to reduce infection risk
• Follow prescribed treatments consistently
• Monitor for signs of infection and seek prompt care
• Engage in gentle exercise to preserve joint mobility

When to Seek Professional Help

Seek medical attention if experiencing:

• Persistent joint pain or swelling in the left hand
• Unexplained fever or signs of infection
• Fatigue or weakness that interferes with daily activities
• Abdominal pain or fullness suggesting splenomegaly
• Unusual bruising or bleeding (indicating low platelets)

Tips for Medical Coders

Document the specific site (left hand) and confirm the presence of Felty's syndrome criteria (rheumatoid arthritis, splenomegaly, neutropenia) in the medical record. Ensure the code M05.042 is used only when the left hand is explicitly documented as affected. Verify that the diagnosis aligns with clinical findings to support accurate coding.